User profiles for Marina Mesquida
Marina MesquidaRoche Verified email at roche.com Cited by 2836 |
Anti–interleukin‐6 receptor tocilizumab for severe juvenile idiopathic arthritis–associated uveitis refractory to anti–tumor necrosis factor therapy: a multicenter study of …
…, B López‐Montesinos, M Mesquida… - Arthritis & …, 2017 - Wiley Online Library
Objective To assess the efficacy of tocilizumab (TCZ) for the treatment of juvenile idiopathic
arthritis (JIA)–associated uveitis. Methods We conducted a multicenter study of patients with …
arthritis (JIA)–associated uveitis. Methods We conducted a multicenter study of patients with …
Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients
…, E Beltrán, J Sánchez-Bursón, M Mesquida… - …, 2014 - academic.oup.com
Objective. The aim of this study was to assess the efficacy of anti-TNF-α therapy in refractory
uveitis due to Behçet’s disease (BD). Methods. We performed a multicentre study of 124 …
uveitis due to Behçet’s disease (BD). Methods. We performed a multicentre study of 124 …
Epidemiology of uveitis in a Western urban multiethnic population. The challenge of globalization
V Llorenç, M Mesquida… - Acta …, 2015 - Wiley Online Library
Purpose To report the anatomical pattern and etiological spectrum of uveitis in an urban
multi‐ethnic population from B arcelona, S pain. General and specific epidemiological data for …
multi‐ethnic population from B arcelona, S pain. General and specific epidemiological data for …
Anti-IL6-receptor tocilizumab in refractory and noninfectious uveitic cystoid macular edema: multicenter study of 25 patients
N Vegas-Revenga, V Calvo-Río, M Mesquida… - American Journal of …, 2019 - Elsevier
… In the last 2 years, 2 remarkable studies have been published, by Mesquida and associates
24 and by Sepah and associates. Mesquida and associates 24 reported 12 patients with …
24 and by Sepah and associates. Mesquida and associates 24 reported 12 patients with …
Tocilizumab treatment for refractory uveitis-related cystoid macular edema
Background This retrospective study investigated the efficacy of tocilizumab (TCZ), a fully
humanized antibody that binds both to soluble and membrane bound IL-6 receptors, for the …
humanized antibody that binds both to soluble and membrane bound IL-6 receptors, for the …
Evidence for tocilizumab as a treatment option in refractory uveitis associated with juvenile idiopathic arthritis
Objective. To report on experience using the anti-interleukin 6 receptor antibody tocilizumab
(TCZ) to treat severe and therapy-refractory uveitis associated with juvenile idiopathic …
(TCZ) to treat severe and therapy-refractory uveitis associated with juvenile idiopathic …
Long-term effects of tocilizumab therapy for refractory uveitis-related macular edema
… Author links open overlay panel Marina Mesquida MD 1 , Blanca Molins PhD 2 , Victor
Llorenç MD, PhD 1 , Maite Sainz de la Maza MD, PhD 1 , Alfredo Adán MD, PhD 1 …
Llorenç MD, PhD 1 , Maite Sainz de la Maza MD, PhD 1 , Alfredo Adán MD, PhD 1 …
The role of inflammation in diabetic eye disease
M Mesquida, F Drawnel, S Fauser - Seminars in Immunopathology, 2019 - Springer
Mounting evidence suggests that immunological mechanisms play a fundamental role in
the pathogenesis of diabetic retinopathy (DR) and diabetic macular edema (DME). …
the pathogenesis of diabetic retinopathy (DR) and diabetic macular edema (DME). …
Adalimumab for the treatment of Behçet's disease: experience in 19 patients
D Perra, MA Alba, JL Callejas, M Mesquida… - …, 2012 - academic.oup.com
Objective. To describe the experience of two tertiary Spanish centres (Hospital Clínico San
Cecilio, Granada and Hospital Clínic, Barcelona) with the use of adalimumab for the …
Cecilio, Granada and Hospital Clínic, Barcelona) with the use of adalimumab for the …
Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients
…, V Calvo-Río, R Blanco, M Mesquida… - Seminars in arthritis and …, 2015 - Elsevier
Objectives To assess anti-TNF-α therapy response in uveitis associated with sarcoidosis
refractory to conventional immunosuppressive therapy. Methods Open-label, multicenter, …
refractory to conventional immunosuppressive therapy. Methods Open-label, multicenter, …